LFVN
LifeVantage Corporation
Price Chart
Latest Quote
$6.27
+0.04 (+0.64%)
Current Price
| Previous Close | $6.23 |
| Open | $6.14 |
| Day High | $6.42 |
| Day Low | $6.14 |
| Volume | 58,521 |
Stock Information
| Quarterly Dividend / Yield | $0.20 / 3.22% |
| Shares Outstanding | 12.62M |
| Quarterly Dividend Yield | 3.22% |
| Quarterly Dividend | $0.20 |
| Total Debt | $10.21M |
| Cash Equivalents | $12.48M |
| Revenue | $195.32M |
| Net Income | $5.75M |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Market Cap | $79.10M |
| P/E Ratio | 13.93 |
| EPS (TTM) | $0.45 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $76.32M |
| Sales | $195.32M |
| Income | $5.75M |
| Book/sh | $2.64 |
| Cash/sh | $0.99 |
| Employees | 232 |
Financial Ratios
| Quick Ratio | 0.85 |
| Current Ratio | 1.96 |
| Debt/Eq | 30.61 |
| EPS Growth TTM | -60.70% |
Returns & Margins
| ROA | 6.44% |
| ROE | 17.08% |
| Gross Margin | 78.14% |
| Operating Margin | 4.07% |
| Profit Margin | 2.94% |
Ownership
| Insider Ownership | 16.42% |
| Institutional Ownership | 67.45% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 13.73 |
| PEG | 0.36 |
| P/S | 0.40 |
| P/B | 2.37 |
Analyst Data
| Recommendation | none |
| Target Price | $7.00 |
Technical Indicators
| SMA20 | $7.96 |
| SMA50 | $6.35 |
| SMA200 | $6.50 |
| RSI | 28.16 |
| ATR | 1.2569 |
| Shares Float | 8.95M |
| Short Float | 35.52% |
| Short Ratio | 12.01 |
| Volatility | 0.73 |
| Rel Volume | 0.07 |
Performance History
| Week | +3.47% |
| Month | -8.95% |
| Quarter | +47.09% |
| 6 Months | +6.37% |
| YTD | +5.67% |
| Year | -47.40% |
| 3 Years | +40.26% |
| 5 Years | -4.60% |
| 10 Years | -40.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $6.27 | 58,521 |
| 2026-06-24 | $6.23 | 143,800 |
| 2026-06-23 | $6.18 | 232,800 |
| 2026-06-22 | $6.08 | 324,400 |
| 2026-06-18 | $6.41 | 467,400 |
| 2026-06-17 | $6.06 | 271,600 |
| 2026-06-16 | $6.04 | 850,400 |
| 2026-06-15 | $6.61 | 1,872,900 |
| 2026-06-12 | $9.05 | 503,500 |
| 2026-06-11 | $9.49 | 713,500 |
| 2026-06-10 | $9.48 | 1,016,200 |
| 2026-06-09 | $9.50 | 929,600 |
| 2026-06-08 | $10.70 | 1,449,400 |
| 2026-06-05 | $9.97 | 969,800 |
| 2026-06-04 | $9.31 | 2,306,500 |
| 2026-06-03 | $8.32 | 893,500 |
| 2026-06-02 | $8.62 | 2,557,600 |
| 2026-06-01 | $9.43 | 1,234,100 |
| 2026-05-29 | $7.82 | 448,300 |
| 2026-05-28 | $7.62 | 759,100 |
| 2026-05-27 | $8.00 | 1,221,400 |
| 2026-05-26 | $6.89 | 423,800 |
About LifeVantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.
đ° Latest News
LifeVantage Corporation (NASDAQ:LFVN) Pays A US$0.05 Dividend In Just Three Days
Simply Wall St. âĸ 2026-05-28T11:01:12Z
Do Options Traders Know Something About LifeVantage Stock We Don't?
Zacks âĸ 2026-05-27T15:28:00Z
Lake Street Capital Markets Downgrades LifeVantage Corporation (LFVN) After Weak Q3 Results
Insider Monkey âĸ 2026-05-14T05:29:15Z
Lifevantage Q3 Earnings Call Highlights
MarketBeat âĸ 2026-05-07T02:16:46Z
LifeVantage Corporation Q3 2026 Earnings Call Summary
Moby âĸ 2026-05-07T00:28:50Z
Lifevantage (LFVN) Q3 Earnings and Revenues Miss Estimates
Zacks âĸ 2026-05-06T22:30:21Z
How A Reset Price Target Is Shaping The Evolving Story For LifeVantage (LFVN)
Simply Wall St. âĸ 2026-05-03T18:06:15Z
Strength Seen in Lifevantage (LFVN): Can Its 8.5% Jump Turn into More Strength?
Zacks âĸ 2026-04-28T10:48:00Z
Broadwind And 2 Promising Penny Stocks For Your Investment Radar
Simply Wall St. âĸ 2026-04-24T18:05:33Z
GrowGeneration Leads The Pack Of 3 Promising Penny Stocks
Simply Wall St. âĸ 2026-04-23T18:05:42Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $44,864,000 | $41,440,000 | $43,387,000 | $38,097,000 |
| Cost Of Revenue | $44,864,000 | $41,440,000 | $43,387,000 | $38,097,000 |
| Total Revenue | $228,530,000 | $200,164,000 | $213,398,000 | $206,360,000 |
| Operating Revenue | $200,265,000 | $176,062,000 | $169,214,000 | $158,493,000 |
| Expenses | ||||
| Total Expenses | $216,331,000 | $195,832,000 | $209,139,000 | $198,785,000 |
| Other Income Expense | $-387,000 | $-412,000 | $-458,000 | $-2,874,000 |
| Other Non Operating Income Expenses | $-7,000 | $17,000 | $-85,000 | $41,000 |
| Net Non Operating Interest Income Expense | $431,000 | $430,000 | $198,000 | $-10,000 |
| Operating Expense | $171,467,000 | $154,392,000 | $165,752,000 | $160,688,000 |
| Other Operating Expenses | $102,260,000 | $85,920,000 | $94,687,000 | $97,263,000 |
| General And Administrative Expense | $69,207,000 | $68,472,000 | $71,065,000 | $63,425,000 |
| Selling And Marketing Expense | - | $85,920,000 | $94,687,000 | $97,263,000 |
| Interest Expense | - | - | - | $10,000 |
| Interest Expense Non Operating | - | - | - | $10,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $9,805,000 | $2,937,000 | $2,540,000 | $3,120,000 |
| Net Interest Income | $431,000 | $430,000 | $198,000 | $-10,000 |
| Interest Income | $431,000 | $430,000 | $198,000 | - |
| Normalized Income | $10,109,329 | $3,226,649 | $2,776,855 | $5,058,475 |
| Net Income From Continuing And Discontinued Operation | $9,805,000 | $2,937,000 | $2,540,000 | $3,120,000 |
| Total Operating Income As Reported | $12,199,000 | $4,332,000 | $4,259,000 | $7,575,000 |
| Net Income Common Stockholders | $9,805,000 | $2,937,000 | $2,540,000 | $3,120,000 |
| Net Income | $9,805,000 | $2,937,000 | $2,540,000 | $3,120,000 |
| Net Income Including Noncontrolling Interests | $9,805,000 | $2,937,000 | $2,540,000 | $3,120,000 |
| Net Income Continuous Operations | $9,805,000 | $2,937,000 | $2,540,000 | $3,120,000 |
| Pretax Income | $12,243,000 | $4,350,000 | $3,999,000 | $4,691,000 |
| Interest Income Non Operating | $431,000 | $430,000 | $198,000 | - |
| Operating Income | $12,199,000 | $4,332,000 | $4,259,000 | $7,575,000 |
| Gross Profit | $183,666,000 | $158,724,000 | $170,011,000 | $168,263,000 |
| Special Income Charges | - | - | $0 | $-2,205,000 |
| Per Share | ||||
| Diluted EPS | - | $0.23 | $0.20 | $0.24 |
| Basic EPS | - | $0.24 | $0.20 | $0.24 |
| Other | ||||
| Tax Effect Of Unusual Items | $-75,671 | $-139,351 | $-136,145 | $-976,525 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $15,735,000 | $8,342,000 | $8,211,000 | $10,877,000 |
| Total Unusual Items | $-380,000 | $-429,000 | $-373,000 | $-2,915,000 |
| Total Unusual Items Excluding Goodwill | $-380,000 | $-429,000 | $-373,000 | $-2,915,000 |
| Reconciled Depreciation | $3,156,000 | $3,581,000 | $3,579,000 | $3,261,000 |
| EBITDA (Bullshit earnings) | $15,355,000 | $7,913,000 | $7,838,000 | $7,962,000 |
| EBIT | $12,199,000 | $4,332,000 | $4,259,000 | $4,701,000 |
| Diluted NI Availto Com Stockholders | $9,805,000 | $2,937,000 | $2,540,000 | $3,120,000 |
| Tax Provision | $2,438,000 | $1,413,000 | $1,459,000 | $1,571,000 |
| Gain On Sale Of Security | $-380,000 | $-429,000 | $-373,000 | $-710,000 |
| Selling General And Administration | $69,207,000 | $68,472,000 | $71,065,000 | $63,425,000 |
| Other Gand A | $69,207,000 | $68,472,000 | $71,065,000 | $63,425,000 |
| Diluted Average Shares | - | $12,986,000 | $12,567,000 | $13,069,000 |
| Basic Average Shares | - | $12,458,000 | $12,557,000 | $12,886,000 |
| Write Off | - | - | $0 | $2,205,000 |
| Gain On Sale Of Ppe | - | - | - | $0 |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $34,396,000 | $25,668,000 | $34,194,000 | $30,929,000 |
| Total Assets | $71,958,000 | $60,299,000 | $66,123,000 | $70,706,000 |
| Total Non Current Assets | $21,064,000 | $22,653,000 | $21,839,000 | $23,749,000 |
| Other Non Current Assets | $601,000 | $680,000 | $569,000 | $1,333,000 |
| Non Current Deferred Assets | $5,970,000 | $4,268,000 | $2,991,000 | $1,289,000 |
| Non Current Deferred Taxes Assets | $5,970,000 | $4,268,000 | $2,991,000 | $1,289,000 |
| Goodwill And Other Intangible Assets | $245,000 | $323,000 | $455,000 | $587,000 |
| Other Intangible Assets | $245,000 | $323,000 | $455,000 | $587,000 |
| Current Assets | $50,894,000 | $37,646,000 | $44,284,000 | $46,957,000 |
| Other Current Assets | $6,095,000 | $2,443,000 | $4,753,000 | $5,205,000 |
| Inventory | $20,669,000 | $15,055,000 | $16,073,000 | $16,472,000 |
| Receivables | $3,929,000 | $3,262,000 | $1,853,000 | $5,090,000 |
| Taxes Receivable | $635,000 | $313,000 | $241,000 | $1,752,000 |
| Accounts Receivable | $3,294,000 | $2,949,000 | $1,612,000 | $3,338,000 |
| Cash Cash Equivalents And Short Term Investments | $20,201,000 | $16,886,000 | $21,605,000 | $20,190,000 |
| Cash And Cash Equivalents | $20,201,000 | $16,886,000 | $21,605,000 | $20,190,000 |
| Investmentin Financial Assets | - | - | - | $0 |
| Prepaid Assets | - | - | - | $5,205,000 |
| Debt | ||||
| Total Debt | $11,678,000 | $13,612,000 | $13,087,000 | $15,755,000 |
| Long Term Debt And Capital Lease Obligation | $9,811,000 | $11,801,000 | $11,566,000 | $13,154,000 |
| Current Debt And Capital Lease Obligation | $1,867,000 | $1,811,000 | $1,521,000 | $2,601,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $37,317,000 | $34,308,000 | $31,474,000 | $39,190,000 |
| Total Non Current Liabilities Net Minority Interest | $10,100,000 | $11,999,000 | $11,865,000 | $13,462,000 |
| Other Non Current Liabilities | $289,000 | $198,000 | $299,000 | $308,000 |
| Current Liabilities | $27,217,000 | $22,309,000 | $19,609,000 | $25,728,000 |
| Current Deferred Liabilities | $711,000 | $860,000 | $834,000 | $78,000 |
| Payables And Accrued Expenses | $19,309,000 | $18,027,000 | $14,152,000 | $22,078,000 |
| Payables | $14,485,000 | $15,316,000 | $12,606,000 | $17,414,000 |
| Other Payable | $7,237,000 | $6,569,000 | $6,651,000 | $7,285,000 |
| Total Tax Payable | $2,189,000 | $2,460,000 | $1,730,000 | $2,206,000 |
| Income Tax Payable | $0 | $202,000 | $0 | $453,000 |
| Accounts Payable | $5,059,000 | $6,287,000 | $4,225,000 | $7,923,000 |
| Equity | ||||
| Common Stock Equity | $34,641,000 | $25,991,000 | $34,649,000 | $31,516,000 |
| Total Equity Gross Minority Interest | $34,641,000 | $25,991,000 | $34,649,000 | $31,516,000 |
| Stockholders Equity | $34,641,000 | $25,991,000 | $34,649,000 | $31,516,000 |
| Gains Losses Not Affecting Retained Earnings | $-1,175,000 | $-1,916,000 | $-1,361,000 | $-1,123,000 |
| Other | ||||
| Ordinary Shares Number | $12,429,000 | $12,510,000 | $12,622,000 | $12,493,000 |
| Share Issued | $12,429,000 | $12,510,000 | $12,622,000 | $12,493,000 |
| Tangible Book Value | $34,396,000 | $25,668,000 | $34,194,000 | $30,929,000 |
| Invested Capital | $34,641,000 | $25,991,000 | $34,649,000 | $31,516,000 |
| Working Capital | $23,677,000 | $15,337,000 | $24,675,000 | $21,229,000 |
| Capital Lease Obligations | $11,678,000 | $13,612,000 | $13,087,000 | $15,755,000 |
| Total Capitalization | $34,641,000 | $25,991,000 | $34,649,000 | $31,516,000 |
| Additional Paid In Capital | $139,962,000 | $136,644,000 | $134,314,000 | $131,075,000 |
| Capital Stock | $1,000 | $1,000 | $1,000 | $1,000 |
| Common Stock | $1,000 | $1,000 | $1,000 | $1,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $9,811,000 | $11,801,000 | $11,566,000 | $13,154,000 |
| Current Deferred Revenue | $711,000 | $860,000 | $834,000 | $78,000 |
| Current Capital Lease Obligation | $1,867,000 | $1,811,000 | $1,521,000 | $2,601,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $5,330,000 | $1,611,000 | $3,102,000 | $971,000 |
| Current Accrued Expenses | $4,824,000 | $2,711,000 | $1,546,000 | $4,664,000 |
| Net PPE | $14,248,000 | $17,382,000 | $17,824,000 | $20,540,000 |
| Accumulated Depreciation | $-17,412,000 | $-14,510,000 | $-14,151,000 | $-15,686,000 |
| Gross PPE | $31,660,000 | $31,892,000 | $31,975,000 | $36,226,000 |
| Leases | $5,101,000 | $5,040,000 | $4,734,000 | $6,034,000 |
| Other Properties | $25,039,000 | $25,335,000 | $25,714,000 | $28,821,000 |
| Machinery Furniture Equipment | $1,520,000 | $1,517,000 | $1,527,000 | $1,371,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $17,739,000 | $11,841,000 | $12,153,000 | $12,674,000 |
| Raw Materials | $2,930,000 | $3,214,000 | $3,920,000 | $3,798,000 |
| Investments And Advances | - | - | - | $0 |
| Available For Sale Securities | - | - | - | - |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Cash Flow | $11,878,000 | $12,197,000 | $6,828,000 | $7,959,000 |
| Cash Flow From Continuing Operating Activities | $11,878,000 | $12,197,000 | $6,828,000 | $7,959,000 |
| Operating Gains Losses | $-4,000 | $2,000 | $33,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-1,371,000 | $-2,245,000 | $-3,067,000 | $-1,530,000 |
| Investing Cash Flow | $-1,367,000 | $-2,245,000 | $-3,059,000 | $-1,530,000 |
| Cash Flow From Continuing Investing Activities | $-1,367,000 | $-2,245,000 | $-3,059,000 | $-1,530,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-5,811,000 | $-7,651,000 | $-1,023,000 | $-9,079,000 |
| Financing Cash Flow | $-7,598,000 | $-14,417,000 | $-2,357,000 | $-8,952,000 |
| Cash Flow From Continuing Financing Activities | $-7,598,000 | $-14,417,000 | $-2,357,000 | $-8,952,000 |
| Cash Dividends Paid | $-2,067,000 | $-6,940,000 | $-1,586,000 | $-378,000 |
| Common Stock Dividend Paid | $-2,067,000 | $-6,940,000 | $-1,586,000 | - |
| Net Common Stock Issuance | $-5,811,000 | $-7,651,000 | $-1,023,000 | $-9,079,000 |
| Net Other Financing Charges | - | $-97,000 | - | - |
| Other | ||||
| Interest Paid Supplemental Data | $2,000 | $21,000 | $5,000 | - |
| Income Tax Paid Supplemental Data | $4,918,000 | $2,306,000 | $1,873,000 | - |
| End Cash Position | $20,201,000 | $16,886,000 | $21,605,000 | $20,190,000 |
| Beginning Cash Position | $16,886,000 | $21,605,000 | $20,190,000 | $23,174,000 |
| Effect Of Exchange Rate Changes | $402,000 | $-254,000 | $3,000 | $-461,000 |
| Changes In Cash | $2,913,000 | $-4,465,000 | $1,412,000 | $-2,523,000 |
| Proceeds From Stock Option Exercised | $280,000 | $271,000 | $252,000 | $505,000 |
| Common Stock Payments | $-5,811,000 | $-7,651,000 | $-1,023,000 | $-9,079,000 |
| Net PPE Purchase And Sale | $-1,367,000 | $-2,245,000 | $-3,059,000 | $-1,530,000 |
| Sale Of PPE | $4,000 | $0 | $8,000 | $0 |
| Purchase Of PPE | $-1,371,000 | $-2,245,000 | $-3,067,000 | $-1,530,000 |
| Change In Working Capital | $-6,550,000 | $2,380,000 | $-2,558,000 | $-4,100,000 |
| Change In Other Current Liabilities | $-1,780,000 | $-1,339,000 | $-1,601,000 | $-1,979,000 |
| Change In Other Current Assets | $72,000 | $-55,000 | $-157,000 | $139,000 |
| Change In Payables And Accrued Expense | $4,541,000 | $2,327,000 | $-5,205,000 | $804,000 |
| Change In Accrued Expense | $6,037,000 | $-176,000 | $-770,000 | $357,000 |
| Change In Payable | $-1,496,000 | $2,503,000 | $-4,435,000 | $447,000 |
| Change In Account Payable | $-1,295,000 | $2,301,000 | $-3,982,000 | $824,000 |
| Change In Tax Payable | $-201,000 | $202,000 | $-453,000 | $-377,000 |
| Change In Income Tax Payable | $-201,000 | $202,000 | $-453,000 | $-377,000 |
| Change In Prepaid Assets | $-3,603,000 | $2,280,000 | $1,276,000 | $-551,000 |
| Change In Inventory | $-5,216,000 | $662,000 | $61,000 | $-1,186,000 |
| Change In Receivables | $-564,000 | $-1,495,000 | $3,068,000 | $-1,327,000 |
| Changes In Account Receivables | $-242,000 | $-1,424,000 | $1,558,000 | $-614,000 |
| Other Non Cash Items | $1,472,000 | $1,294,000 | $1,748,000 | $1,786,000 |
| Stock Based Compensation | $5,702,000 | $3,280,000 | $3,188,000 | $1,768,000 |
| Deferred Income Tax | $-1,703,000 | $-1,277,000 | $-1,702,000 | $-81,000 |
| Depreciation Amortization Depletion | $3,156,000 | $3,581,000 | $3,579,000 | $3,261,000 |
| Depreciation And Amortization | $3,156,000 | $3,581,000 | $3,579,000 | $3,261,000 |
| Amortization Cash Flow | $100,000 | $100,000 | $100,000 | - |
| Amortization Of Intangibles | $100,000 | $100,000 | $100,000 | - |
| Depreciation | $3,100,000 | $3,400,000 | $3,400,000 | $5,047,000 |
| Gain Loss On Sale Of PPE | $-4,000 | $2,000 | $33,000 | $0 |
| Net Income From Continuing Operations | $9,805,000 | $2,937,000 | $2,540,000 | $3,120,000 |
| Asset Impairment Charge | - | - | $0 | $2,205,000 |
| Repayment Of Debt | - | - | - | $0 |
| Net Issuance Payments Of Debt | - | - | - | $0 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
Fetched: 2026-06-19